General MedicationsINJECTIONStandard
SODIUM NITROPRUSSIDE
SODIUM NITROPRUSSIDE
Standard Dose
25MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview SODIUM NITROPRUSSIDE is listed in Drugs@FDA under application 214971 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM NITROPRUSSIDE Form and strength INJECTABLE;INJECTION - 25MG/ML Sponsor BE PHARMS Submission history Latest submission status date: 2021-07-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview SODIUM NITROPRUSSIDE is listed in Drugs@FDA under application 214971 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM NITROPRUSSIDE Form and strength INJECTABLE;INJECTION - 25MG/ML Sponsor BE PHARMS Submission history Latest submission status date: 2021-07-12 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.